Novopharm Limited v. Eli Lilly and Company, 2010 FC 915 (Atomoxetine*)

Justice Barnes - 2010-09-14

Read full decision. Automatically generated summary:

In this action Novopharm Ltd. (now known as Teva Canada Limited but hereafter referred to as Novopharm) seeks a declaration under ss. 60(1) of the Patent Act, R.S.C. 1985,c. P-4 (Patent Act) that Eli Lilly and Company's (hereafter referred to as Lilly) Canadian Patent No. 2,209,735 (the 735 Patent) is invalid and void.

Decision relates to:


Canadian Intellectual Property